LOW vs ORKA · P/E 18, rev $49.03B vs $4.27B cap
Lowe's Companies Inc (LOW) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
ORKA does not have a complete income-statement cache yet.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the LOW and ORKA stock pages for the full models.
Not investment advice.